Skip to content
10-Q

Quarterly Report

Sio Gene Therapies Inc.

0001636050-23-000007

← back to feed
Filed
Feb 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Feb 10, 2023 73.98M sh
Shares Diluted Q3 2023 · Dec 31, 2022 73.98M sh
Shares Diluted Q3 2023 · Dec 31, 2022 73.91M sh
Shares Diluted Q3 2023 · Dec 31, 2021 73.34M sh
Shares Diluted Q3 2023 · Dec 31, 2021 73.05M sh
Operating Cash Flow Q3 2023 · Dec 31, 2022 −$18.69M
Operating Cash Flow Q3 2023 · Dec 31, 2021 −$42.52M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $46.13M
Cash And Equivalents Q3 2023 · Mar 31, 2022 $63.73M
Cash And Equivalents Q3 2023 · Dec 31, 2021 $81.91M
Cash And Equivalents Q3 2023 · Mar 31, 2021 $118.99M
Stockholders Equity Q3 2023 · Dec 31, 2022 $45.12M
Stockholders Equity Q3 2023 · Sep 30, 2022 $48.91M
Stockholders Equity Q3 2023 · Jun 30, 2022 $51.78M
Stockholders Equity Q3 2023 · Mar 31, 2022 $60.35M
Stockholders Equity Q3 2023 · Dec 31, 2021 $76.27M
Stockholders Equity Q3 2023 · Sep 30, 2021 $99.36M
Stockholders Equity Q3 2023 · Jun 30, 2021 $113.3M
Stockholders Equity Q3 2023 · Mar 31, 2021 $123.37M
Current Liabilities Q3 2023 · Dec 31, 2022 $2.15M
Current Liabilities Q3 2023 · Mar 31, 2022 $13M
Total Liabilities Q3 2023 · Dec 31, 2022 $2.15M
Total Liabilities Q3 2023 · Mar 31, 2022 $14.73M
Current Assets Q3 2023 · Dec 31, 2022 $47.27M
Current Assets Q3 2023 · Mar 31, 2022 $71.74M
Total Assets Q3 2023 · Dec 31, 2022 $47.27M
Total Assets Q3 2023 · Mar 31, 2022 $75.08M
Eps Diluted Q3 2023 · Dec 31, 2022 −$0.05
Eps Diluted Q3 2023 · Dec 31, 2022 −$0.21
Eps Diluted Q3 2023 · Dec 31, 2021 −$0.35
Eps Diluted Q3 2023 · Dec 31, 2021 −$0.80
Eps Basic Q3 2023 · Dec 31, 2022 −$0.05
Eps Basic Q3 2023 · Dec 31, 2022 −$0.21
Eps Basic Q3 2023 · Dec 31, 2021 −$0.35
Eps Basic Q3 2023 · Dec 31, 2021 −$0.80
Sga Expense Q3 2023 · Dec 31, 2022 $2.6M
Sga Expense Q3 2023 · Dec 31, 2022 $8.53M
Sga Expense Q3 2023 · Dec 31, 2021 $4.09M
Sga Expense Q3 2023 · Dec 31, 2021 $17.69M
Rd Expense Q3 2023 · Dec 31, 2022 $1.88M
Rd Expense Q3 2023 · Dec 31, 2022 $7.76M
Rd Expense Q3 2023 · Dec 31, 2021 $21.29M
Rd Expense Q3 2023 · Dec 31, 2021 $40.79M
Net Income Q3 2023 · Dec 31, 2022 −$4.02M
Net Income Q3 2023 · Dec 31, 2022 −$15.51M
Net Income Q3 2023 · Sep 30, 2022 −$3.08M
Net Income Q3 2023 · Jun 30, 2022 −$8.41M
Net Income Q3 2023 · Mar 31, 2022 −$71.9M
Net Income Q3 2023 · Dec 31, 2021 −$25.46M
Net Income Q3 2023 · Dec 31, 2021 −$58.56M
Net Income Q3 2023 · Sep 30, 2021 −$21.24M
Net Income Q3 2023 · Jun 30, 2021 −$11.87M
Operating Income Q3 2023 · Dec 31, 2022 −$4.02M
Operating Income Q3 2023 · Dec 31, 2022 −$15.51M
Operating Income Q3 2023 · Dec 31, 2021 −$25.46M
Operating Income Q3 2023 · Dec 31, 2021 −$58.59M